Alkermes, Inc. (ALKS)

NetscribeBiotech (88.86) Submitted: 2/13/07 6:33 AM : Start Price: $16.54 ALKS Score: 0.50

Alkermes, Inc. (Alkermes) is a biotechnology company that develops products based on drug delivery technologies. The company has two commercial products: Risperdal Consta (risperidone), for use in schizophrenia and Vivitrol, a once-monthly injection ...

Report this Post Replies: 0 | Reply | Permalink

Sanjiv523 (< 20) Submitted: 8/18/06 2:44 AM : Start Price: $16.41 ALKS Score: -6.21

Alkermes has among the most enticing platforms in the business. As one of the leaders in the extended release market, it allows companies to increase the convenience of administration of their drugs. A drug given less often cuts costs for the medical...

Report this Post Replies: 0 | Reply | Permalink

stratton6 (99.69) Submitted: 8/06/06 5:08 PM : Start Price: $16.93 ALKS Score: -9.75

Drug delivery technologies, inhalation and extended release microspheres. This will be a hottly competitive market in the comming years. Alkermes has a few good collaborations.

Report this Post Replies: 0 | Reply | Permalink

dcl12 (91.52) Submitted: 1/24/07 8:26 PM : Start Price: $14.60 ALKS Score: 9.84

There are many analysis in more depth than what I can add though it is worth noting that ALKS has big pharma partners. The pipeline is strong.

I think we will see another shake out dip (~$12-$13 ) in the stock before we see the major investment hou...

Report this Post Replies: 0 | Reply | Permalink

heniwa (48.75) Submitted: 10/06/06 5:42 PM : Start Price: $15.75 ALKS Score: -0.59

Alkermes has low scientific and regulatory risk, is a preferred partner of large Pharma companies, and has a good pipeline.

Report this Post Replies: 0 | Reply | Permalink

Charl9s (27.79) Submitted: 8/20/06 11:46 AM : Start Price: $16.26 ALKS Score: -5.63

Company is testing new delivery system for drugs.

Report this Post Replies: 0 | Reply | Permalink

indyjoneses (99.86) Submitted: 8/28/08 12:11 PM : Start Price: $13.27 ALKS Score: 10.31

Irrational market beating for potential molecule, which may or may not have a non-existent problem. Should do well ihf/when Long Acting Byetta gets to the market

Report this Post Replies: 0 | Reply | Permalink

Parobek (< 20) Submitted: 2/08/08 8:41 PM : Start Price: $13.60 ALKS Score: 10.07

Week #2 - Tuesday: 'Stock Pick of the Day'

Report this Post Replies: 0 | Reply | Permalink

rhovero (78.26) Submitted: 3/07/08 7:23 PM : Start Price: $10.76 ALKS Score: 30.65

Byetta LAR should be approved in 2009-2010

Report this Post Replies: 0 | Reply | Permalink

mdriver78 (< 20) Submitted: 4/15/08 9:05 AM : Start Price: $11.23 ALKS Score: 28.27

Forecast 38-percent earings growth over the next 5 years.

Report this Post Replies: 0 | Reply | Permalink